The Column Group

The Column Group is a leading life sciences venture capital firm that invests in transformative biotechnology companies. Founded by David Goeddel, a pioneer in the biotechnology industry and co-founder of Genentech, the firm combines deep scientific expertise with company-building experience.

Location
San Francisco, California, USA
Founded
2006
AUM
$2B+
Investment Range
$10M - $100M
Portfolio Companies
1
Focus
biotech-focused
Fund Stages
seed, series-a, series-b, series-c, growth

Portfolio Companies

NameLocationFoundedCategories
Eikon TherapeuticsHayward, California, USA2019
drug-discoveryai-drug-discovery+3